Skip to main content
Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
199.86
-1.39 (-0.69%)
Dec 3, 2024, 2:04 PM EST - Market open

CRL Revenue

Charles River Laboratories International had revenue of $1.01B in the quarter ending September 28, 2024, a decrease of -1.64%. This brings the company's revenue in the last twelve months to $4.06B, down -3.67% year-over-year. In the year 2023, Charles River Laboratories International had annual revenue of $4.13B with 3.86% growth.

Revenue (ttm)
$4.06B
Revenue Growth
-3.67%
P/S Ratio
2.55
Revenue / Employee
$186,281
Employees
21,800
Market Cap
10.19B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 30, 20234.13B153.35M3.86%
Dec 31, 20223.98B435.90M12.31%
Dec 25, 20213.54B616.23M21.08%
Dec 26, 20202.92B302.71M11.55%
Dec 28, 20192.62B355.13M15.67%
Dec 29, 2018 Pro Pro Pro
Dec 30, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 26, 2015 Pro Pro Pro
Dec 27, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Henry Schein 12.50B
Smith & Nephew 5.64B
Encompass Health 5.22B
Catalent 4.42B
Exelixis 2.08B
Medpace Holdings 2.07B
Qiagen 1.97B
Tempus AI 640.44M
Revenue Rankings

CRL News

More News